Executive

Dr. R. Douglas Armstrong - Chief Executive Officer

Dr. Armstrong has over twenty years' experience in the assessment and development of biotechnologies, as well as in-depth corporate management experience at public and private biotechnology, medical device and developmental research companies. Prior to his appointment at TyraTech, Dr. Armstrong was CEO and Chairman of Aastrom Biosciences Inc., which he led from start-up, through development, and a public offering on NASDAQ. He has also served on the boards of VisualSonics Inc., Nephros Therapeutics Inc., Cytomedix Inc., Zellera AG (Germany), and the Burnham Institute, where he also served as the Executive Vice President. In addition, Dr. Armstrong has served as a member of the advisory board of Wolverine Venture Fund, and an advisor to Auxol Capital. Dr. Armstrong is a graduate in Chemistry from the University of Richmond, Virginia and he also holds a PhD in Pharmacology & Toxicology from the Medical College of Virginia, at Virginia Commonwealth University.

Rick Brenner - President and General Manager, Sustainable Solutions

Mr. Brenner is the founding CEO of TyraTech and VP of Business Development for XL TechGroup. He has over 25 years experience in brand building, general management, and entrepreneurial enterprises. Prior to TyraTech, Mr. Brenner's was COO of Teen Mania and President of Calyx & Corolla. His general management roles were preceded by three years at PNV, a telecommunications start-up company, eight years in marketing at Procter & Gamble serving in multiple roles, including marketing Director and six years at Leo Burnett Advertising, in account management. Mr. Brenner received a Bachelor of Science in business administration from the University of Maryland and a Master of Management degree from Northwestern University.

Keith Bigsby - Chief Financial Officer

After qualifying as a Chartered Accountant Mr. Bigsby has had over 30 years of senior financial management and board room experience in the technology sector. Mr. Bigsby has held senior finance positions across Europe, the USA and the Far East, a significant proportion of which has been as Chief Financial Officer (including for publicly listed companies) most recently at Geotrupes Energy Plc and Tadpole Technology Plc. Prior to this he was for six years the European Regional CFO for Wang and held Regional Finance Director roles in the UK and France for Sun Microsystems. He has a significant background in complex business environments, strategic planning and process re-engineering.

Dr. Essam Enan - Chief Scientific Officer

Essam Enan, Ph.D. is a renowned biochemist and toxicologist, and is the inventor of TyraTech's proprietary screening and product. Most recently, Dr Enan has been a research professor at Vanderbilt, and while there he developed the intellectual property that forms the technical foundation for the Company. Dr. Enan manages all technology at TyraTech, including overseeing the Company's laboratories at TyraTech and Vanderbilt University.

Prior to Vanderbilt, Dr. Enan was a faculty member at the University of California, Davis, Institute of Toxicology and Environmental Health. Dr. Enan has devoted the last 32 years to teaching and innovative research, with hundreds of scientific publications in peer-reviewed journals and many patents to his credit. He has become renown in the field of insect repellency, and has a deep knowledge of G-protein coupled receptors, as well as the chemistry and utility of plant essential oils as they apply to the development of molecularly targeted insecticides.